Expert Insights

GlobalData Healthcare Expert Insights

Drug approvals and industry crises, Expert Insights are substantiated by quantitative data and market forecasts taken from our own proprietary research

View our Expert Insights, they provide analyst's views on the latest trends and events in the Healthcare industry.

Expert InsightsRSS Feed

  1. Roche’s Tecentriq Pulls Further Ahead of Rivals in Metastatic Bladder Cancer

    In this Expert Insight, Cai Xuan, Ph.D., GlobalData's Analyst covering Oncology and Hematology, discusses the approval of Roche's Tecentriq for the treatment of locally advanced/metastatic urothelial cancer.

  2. Takeda Bolsters Hematology Biz with Ariad Purchase

    In this Expert Insight, Adam Dion, Msc, GlobalData's Senior Industry Analyst, discusses Takeda's entry into an agreement to purchase the Cambridge-based biotech Ariad Pharmaceuticals for $24 per share in cash, or approximately $5.2 billion.

  3. Encouraging Phase II Data Boost the Prospects of Voclosporin for Lupus Nephritis

    In this Expert Insight, Sebastian Gehrke, Ph.D., GlobalData's Healthcare Analyst, discusses the prospects for voclosporin for the treatment of lupus nephritis and its potential impact on this treatment area.

  4. Sales Boost Expected for Eli Lilly and Boehringer Ingelheim’s Type 2 Diabetes Drug, Jardiance, Following New Indication and Updated Guidelines

    In this Expert Insight, Jesus Cuaron, Ph.D., PPM, GlobaData’s Senior Analyst covering Cardiovascular and Metabolic Disorders, discusses the FDA's approval of a new drug, Jardiance, in reducing the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.

  5. Dipexium’s and Innocoll’s Antibacterial Candidates for Diabetic Foot Infection Flop in Q4 of 2016

    In this Expert Insight, Jesus Cuaron, Ph.D., PPM, GlobaData’s Senior Analyst covering Cardiovascular and Metabolic Disorders, discusses Dipexium Pharmaceuticals and Innocoll's development of two topical antibacterial candidates, Locilex (pexiganan) and Cogenzia (gentamicin-collagen sponge), respectively, for the treatment of diabetic foot ulcers.

© GlobalData 2017. John Carpenter House, 7 Carmelite Street, London EC4 0BS.